Q1FY22 Earnings Presentation

8 Strides Income statement (*m) Key P&L Highlights - Q1FY22 Particulars Q1 FY22 Q4 FY21 Q1 FY21 QoQ YOY Revenues 6,919 9,115 7,847 -24% -12% EBITDA -468 1,602 1,578 -129% -130% EBITDA % -6.8% 17.6% 20.1% Adj PAT¹ - 1,169 Adj EPS1 -13.0 Reconciliation of EBITDA (m) As per SEBI results Profit before exceptional items & tax Less: Interest, Dividend income Q1 FY22 Q4 FY21 Q1FY21 -1,330 768 812 100 101 94 Add Depreciation and Amortization 549 519 491 Add Finance costs 415 416 369 Consolidated EBITDA as per press note -468 1,602 1,578 1. Adj PAT and Adj EPS for Q1 FY22 excludes exceptional items loss of 915m, Biotech and CHC share of loss of 195m, tax credit of *215m on exception items 13

View entire presentation